PH20168A - 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions - Google Patents

7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions

Info

Publication number
PH20168A
PH20168A PH29873A PH29873A PH20168A PH 20168 A PH20168 A PH 20168A PH 29873 A PH29873 A PH 29873A PH 29873 A PH29873 A PH 29873A PH 20168 A PH20168 A PH 20168A
Authority
PH
Philippines
Prior art keywords
carboxymethoxyphenylacetamino
pharmaceutical compositions
cephem derivatives
cephem
derivatives
Prior art date
Application number
PH29873A
Other languages
English (en)
Inventor
Yoshimasa Machida
Shigeto Negi
Seiichiro Nomoto
Takashi Kamiya
Kyosuke Kitoh
Isao Saito
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP21772682A external-priority patent/JPS59108791A/ja
Priority claimed from JP3601783A external-priority patent/JPS59161389A/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of PH20168A publication Critical patent/PH20168A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
PH29873A 1982-12-14 1983-11-23 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions PH20168A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21772682A JPS59108791A (ja) 1982-12-14 1982-12-14 7−カルボキシメトキシフエニルアセトアミド−3−セフエム誘導体、その製造方法およびそれからなる抗菌剤
JP3601783A JPS59161389A (ja) 1983-03-07 1983-03-07 7−カルボキシメトキシフエニルアセトアミドセフエム誘導体,その製造法およびそれからなる抗菌剤

Publications (1)

Publication Number Publication Date
PH20168A true PH20168A (en) 1986-10-09

Family

ID=26375029

Family Applications (1)

Application Number Title Priority Date Filing Date
PH29873A PH20168A (en) 1982-12-14 1983-11-23 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions

Country Status (16)

Country Link
US (1) US4546176A (fr)
KR (1) KR840007012A (fr)
AT (1) ATA435283A (fr)
AU (1) AU2082783A (fr)
BE (1) BE898442A (fr)
CH (1) CH656131A5 (fr)
DE (1) DE3345093A1 (fr)
DK (1) DK572183A (fr)
ES (2) ES528003A0 (fr)
FR (1) FR2569195B1 (fr)
GB (1) GB2132613B (fr)
IT (1) IT1169969B (fr)
NL (1) NL8304272A (fr)
PH (1) PH20168A (fr)
SE (1) SE8306882L (fr)
YU (1) YU237283A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232918A (en) * 1987-07-23 1993-08-03 Imperial Chemical Industries Plc Cephalosporin derivatives
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
EP0366189A3 (fr) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Lactames-quinolones antimicrobiennes
CA2001203C (fr) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Dithiocarbamoyl quinolones antimicrobiens
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
ATE193890T1 (de) * 1990-04-18 2000-06-15 Procter & Gamble Pharma Antimikrobielle chinolonyl-lactame
US5244892A (en) * 1990-10-16 1993-09-14 Kyorin Pharmaceutical Co., Ltd. Cephem compounds, and antibacterial agents
WO1996004286A1 (fr) * 1994-08-02 1996-02-15 The Procter & Gamble Company Procede d'obtention d'antimicrobiens a base de quinolonyle lactame et nouveaux composes intermediaires
WO1996004247A1 (fr) * 1994-08-02 1996-02-15 The Procter & Gamble Company Procede d'elaboration de composes antimicrobiens
US7091196B2 (en) * 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
BRPI0408117A (pt) * 2003-03-05 2006-03-01 Rib X Pharmaceuticals Inc compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
US20070149463A1 (en) * 2003-10-30 2007-06-28 Oyelere Adegboyega K Bifunctional macrolide heterocyclic compounds and methods of making and using the same
EP1699808A1 (fr) * 2003-11-18 2006-09-13 Rib-X Pharmaceuticals, Inc. Composes heterocycliques macrolides bifonctionnels et leurs procedes de fabrication et d'utilisation
JP5383037B2 (ja) * 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ,インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208171A1 (es) * 1972-09-29 1976-12-09 Ciba Geigy Ag Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico
US4338439A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins
SE8009049L (sv) * 1980-03-04 1981-09-05 Eisai Co Ltd 7alfa-metoxicefalosporinderivat, sett for framstellning derav och antibakteriella lekemedel innehallande dessa foreningar
US4468394A (en) * 1981-04-02 1984-08-28 Eisai Co., Ltd. Cephalosporin compounds

Also Published As

Publication number Publication date
GB2132613B (en) 1986-05-08
AU2082783A (en) 1984-06-21
SE8306882L (sv) 1984-06-15
FR2569195B1 (fr) 1987-01-09
DE3345093A1 (de) 1984-06-14
GB2132613A (en) 1984-07-11
IT8324122A0 (it) 1983-12-12
FR2569195A1 (fr) 1986-02-21
ES534297A0 (es) 1985-06-01
US4546176A (en) 1985-10-08
IT1169969B (it) 1987-06-03
YU237283A (en) 1986-04-30
GB8329554D0 (en) 1983-12-07
NL8304272A (nl) 1984-07-02
ES8506025A1 (es) 1985-06-16
ATA435283A (de) 1986-12-15
DK572183D0 (da) 1983-12-13
BE898442A (fr) 1984-06-13
KR840007012A (ko) 1984-12-04
SE8306882D0 (sv) 1983-12-13
CH656131A5 (de) 1986-06-13
DK572183A (da) 1984-06-27
ES528003A0 (es) 1985-06-16
ES8505691A1 (es) 1985-06-01

Similar Documents

Publication Publication Date Title
IL72028A0 (en) Aminomethyl-oxooxazolidinylbenzene derivatives and pharmaceutical compositions containing them
IL69955A (en) 1-phenyl-2-piperidinoalkanol derivatives,their preparation and pharmaceutical compositions containing them
IL68913A (en) 3-aminoalkyl-1h-indole-5-alkan-sulphonamide derivatives,their preparation and pharmaceutical compositions containing them
IL69157A0 (en) Fluoromorphinan derivatives,their preparation and pharmaceutical compositions containing them
IL72566A (en) Androst-5-en-17-one and 5alpha-androstan-17-one derivatives and pharmaceutical compositions containing the same
GB2091262B (en) 3-aminoprpoxyaryl derivatives their preparation and pharmaceutical compositions containing them
NZ210633A (en) Glycerol derivatives and pharmaceutical compositions thereof
NZ201520A (en) Substituted aminopyridazines and pharmaceutical compositions
IL68360A0 (en) Imidazopyrazolopyrimidine derivatives,their preparation and pharmaceutical compositions containing them
NZ209064A (en) N 6 -diarylalkyl-adenosine derivatives and pharmaceutical compositions
NZ206636A (en) Pyridine derivatives and pharmaceutical compositions
PH17562A (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions
PH20168A (en) 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions
IL68817A0 (en) Oxoazetidine derivatives,their preparation and pharmaceutical compositions containing them
ZW16583A1 (en) Milbemycind derivatives their preparation and compositions containing them
NZ209095A (en) Piperidinoquinazolines and pharmaceutical compositions
NZ208244A (en) Phenyl-pyrazol-3-ones and pharmaceutical compositions
NZ208694A (en) Rooperol derivatives and pharmaceutical compositions
DE3473444D1 (en) Acylindole derivatives and pharmaceutical compositions containing them
IL68496A (en) 8-heteroarylalkyl-ergoline derivatives,their preparation and pharmaceutical compositions containing them
AU576739B2 (en) 2-piperazinyl-or-homo-piperazinyl-quinazoline derivatives and pharmaceutical compositions
PH19575A (en) Cephalosporing derivatives and pharmaceutical compositions thereof
DE3380093D1 (en) 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL73224A (en) 2-dioxacycloalkylthiopenem derivatives and pharmaceutical compositions containing them
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions